RNU6-1262P

Across TCGA pan-cancer cohorts, RNU6-1262P RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RNU6-1262P data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RNU6-1262P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1262P expression acts as an unfavorable survival marker, although some lineages such as ACC and LIHC show a favorable association.

LUSC, KIRC, and ACC are the cancer types where RNU6-1262P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Quartile	III,IV	0.175	0.897	<.001	30	view →
KIRC	DFS	Median	All	0.514	0.698	<.001	29	view →
ACC	DFS	Tertile	III,IV	0.813	0.283	.008	20	view →
THCA	DFS	Median	III,IV	0.407	0.847	.011	20	view →
LIHC	DFS	Tertile	III,IV	0.846	0.244	.003	18	view →
SKCM	DFS	Quartile	All	0.700	0.574	.007	12	view →
ESCA	DFS	Tertile	IV	0.221	0.704	.024	9	view →
HNSC	DFS	Tertile	IV	0.729	0.586	.018	8	view →
LGG	DFS	Quartile	All	0.780	0.868	.015	7	view →
UCS	DFS	Median	IV	0.811	0.514	.039	6	view →
GBM	DFS	Tertile	All	0.423	0.228	.025	6	view →
READ	DFS	Tertile	IV	0.179	0.936	.024	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

RNU6-1262P–LUSC (DFS)

Open the LUSC breakdown →